Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, Large B-Cell, Diffuse 6Multiple Myeloma 5Lymphoma, T-Cell, Cutaneous 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma 5Leukemia, Myeloid, Acute 5Leukemia, Lymphocytic, Chronic, B-Cell 5Congenital Abnormalities 5Sezary Syndrome 4Neoplasms, Plasma Cell 4Mycosis Fungoides 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Accelerated Phase 4Burkitt Lymphoma 4Breast Neoplasms 4Blast Crisis 4Uterine Cervical Neoplasms 3Myelodysplastic Syndromes 3Leukemia, Hairy Cell 3Leukemia 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Uterine Cervical Dysplasia 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Stomach Neoplasms 2

Interventions

fludarabine phosphate 8Rituximab 8Cyclophosphamide 7Tacrolimus 5Mycophenolic Acid 4Antilymphocyte Serum 4Whole-Body Irradiation 3Methotrexate 3Cyclosporine 3Busulfan 3fludarabine 2alvocidib 2Sirolimus 2Peripheral Blood Stem Cell Transplantation 2Filgrastim 2Cord Blood Stem Cell Transplantation 2thymoglobulin 1tanespimycin 1obatoclax 1nelarabine 1merphos 1immunotoxin HA22 1cytokine inducible SH2-containing protein 1Tetradecanoylphorbol Acetate 1Sunitinib 1Polymerase Chain Reaction 1Pharmacogenomic Testing 1Oxycodone 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Prolymphocytic × Flow Cytometry × Clear all
NCT00904514 2018-10-05

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

National Institutes of Health Clinical Center (CC)

Terminated
241 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmOther solid neoplasmThoracic

Congenital Abnormalities, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Brenner Tumor, Burkitt Lymphoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Hodgkin Disease, Leukemia, Hairy Cell, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Neoplasms, Pancreatic Neoplasms, Salivary Gland Neoplasms, Sezary Syndrome, Stomach Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡